Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Supratentorial Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Medulloblastoma 1Brain Neoplasms 1

Interventions

sodium thiosulfate 1Therapeutics 1Sorafenib 1Psychiatric Rehabilitation 1Ocoxin 1Melphalan 1Mannitol 1Ifosfamide 1ICE protocol 5 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Drug Therapy 1Cyclophosphamide 1Cisplatin 1Carboplatin 1Bevacizumab 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplasms, Germ Cell and Embryonal × Mannitol × Clear all
NCT00983398 2021-10-26

Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors

OHSU Knight Cancer Institute

Phase 1/2 Unknown
17 enrolled
CNS

Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡